Age and height predict neuropathy risk in patients with HIV prescribed stavudine.
about
Mitochondrial DNA subhaplogroups L0a2 and L2a modify susceptibility to peripheral neuropathy in malawian adults on stavudine containing highly active antiretroviral therapyScreening for HIV-associated peripheral neuropathy in resource-limited settingsHepatitis C seropositivity is not a risk factor for sensory neuropathy among patients with HIV.Neurological and psychiatric adverse effects of antiretroviral drugs.Implementation of a validated peripheral neuropathy screening tool in patients receiving antiretroviral therapy in Mombasa, KenyaIncident neuropathy in HIV-infected patients on HAARTSensory, psychological, and metabolic dysfunction in HIV-associated peripheral neuropathy: A cross-sectional deep profiling study.Mitochondrial dysfunction in distal axons contributes to human immunodeficiency virus sensory neuropathyPrevalence of peripheral neuropathy and its associated demographic and health status characteristics, among people on antiretroviral therapy in Rwanda.Sex differences in the incidence of peripheral neuropathy among Kenyans initiating antiretroviral therapyPredictors of new-onset distal neuropathic pain in HIV-infected individuals in the era of combination antiretroviral therapy.Peripheral neuropathy in HIV: prevalence and risk factorsEpidermal nerve fiber density, oxidative stress, and mitochondrial haplogroups in HIV-infected Thais initiating therapyThe relationship between race and HIV-distal sensory polyneuropathy in a large cohort of US womenSensory neuropathy and metabolic risk factors in human immune deficiency virus infected South Africans receiving protease inhibitors.Development, Validation, and Field-Testing of an Instrument for Clinical Assessment of HIV-Associated Neuropathy and Neuropathic Pain in Resource-Restricted and Large Population Study SettingsDistal leg epidermal nerve fiber density as a surrogate marker of HIV-associated sensory neuropathy risk: risk factors and change following initial antiretroviral therapy.Neurologic disorders incidence in HIV+ vs HIV- men: Multicenter AIDS Cohort Study, 1996-2011.HIV-associated sensory neuropathy in HIV-1 infected patients at the Douala General Hospital in Cameroon: a cross-sectional study.Determinants of epidermal nerve fibre density in antiretroviral-naïve HIV-infected individualsIncreased incidence of symptomatic peripheral neuropathy among adults receiving stavudine- versus zidovudine-based antiretroviral regimens in Kenya.Hypertriglyceridemia in combination antiretroviral-treated HIV-positive individuals: potential impact on HIV sensory polyneuropathyHIV-related neuropathy: current perspectives.Prevalent neuropathy in a cohort of HIV-infected Kenyan sex workers using antiretroviral drugs.HIV-associated sensory neuropathy: risk factors and genetics.Pathogenesis of HIV-associated sensory neuropathy: evidence from in vivo and in vitro experimental models.A case of possible darunavir/ritonavir-induced peripheral neuropathy: case description and review of the literature.Painful HIV-associated sensory neuropathy.The appropriate use of neurostimulation of the spinal cord and peripheral nervous system for the treatment of chronic pain and ischemic diseases: the Neuromodulation Appropriateness Consensus Committee.Diagnosing and treating HIV-associated sensory neuropathy: a global perspective.Peripheral neuropathy in HIV patients in sub-Saharan Africa failing first-line therapy and the response to second-line ART in the EARNEST trial.Genetics of HIV-associated sensory neuropathy and related pain in Africans.High prevalence of distal sensory polyneuropathy in antiretroviral-treated and untreated people with HIV in Tanzania.HIV, antiretrovirals, and peripheral neuropathy: A moving target.The role of physiotherapy in the treatment of HIV-related sensory neuropathy: The perceptions and referral practices of physicians
P2860
Q28289556-B47F07EB-FAF9-4775-ADEF-E666FADF66A1Q33603950-76B39EAC-AA7D-4807-A051-F8422833B973Q33874791-21337A4F-35FF-4AA6-8669-4E999DF74FA6Q34039419-FED449F7-8B5F-491E-B986-3FE6C809BE1DQ34087372-06038A7A-FB9E-4B40-8A43-19C1172FAC8CQ34100209-3F86181A-B0AA-4C2F-B321-40547DFB82B3Q34194723-F94CB682-D9AB-4828-A729-930A34D63E20Q34636367-379B20FC-65CB-499D-9ED7-07DFB6ABDD53Q35060210-A696584A-AD62-49AE-8256-8C88C812035CQ35164547-8BAF435A-4DA7-4D3B-AB98-B8DF5E6BBA60Q35217892-BDB3809D-74C8-4AE9-960C-0C03B1095754Q35384460-D8496569-F2E1-4D38-8300-1E3E6A4C439AQ35594914-71B26D49-8A0C-4F0D-BFD2-4A5B7B6E49B2Q35823133-DBDF7C54-0F2A-4E62-AB94-D662C11CF6F3Q36086086-11785718-2674-43C6-BC91-64D09E29BBF5Q36169291-DEF2EE5E-32A1-4630-A668-07D9454A690AQ36177503-50232361-C7C8-492B-A93A-3C5A18FDD3FFQ36475300-9F47F247-A707-416C-BBD2-EB57B0CF998FQ36478702-5EDC808E-0E54-49AB-BAD8-BC8330369B8CQ36846583-8C07C55C-6CD0-43AF-8058-E61369E5091FQ37053758-28B64079-8D07-4A1D-99ED-28C23588EF2FQ37058951-89BD6772-E6B9-43B6-BDA3-2751D032DAF5Q37178574-DC8071C0-45B7-42C7-B452-86624F4A4877Q37608857-2DE6F8D6-E742-44EE-BB54-754A42731B67Q37988382-09BB5CB5-438C-46F6-96DD-3A7B1ED16DDFQ37998517-08088BCC-0607-4A9B-9C07-AA050CBB95C8Q38087942-57541601-A798-40CC-916C-912791D7A300Q38197249-6D2CDE78-E98E-4AA8-9273-64C0EF8E343BQ38238967-2FD9FA6C-4E87-4447-B03C-B3211E1C25A3Q38778861-E3E31395-79C2-4E67-8D53-9A0D8A6C285DQ38857895-DD0C60B8-F0C3-4D2C-B7AA-CB7BB3330195Q39339843-7AE9032F-AFDB-44A8-92FB-6CAC492BF69FQ43940258-815063A6-67D8-4E6B-9D69-9A6BBBB57D0DQ50061481-3151455E-A66F-4FFD-9E2B-65313D115274Q56974239-AE7AA71F-FB93-497D-BE9A-40B76A31E5AC
P2860
Age and height predict neuropathy risk in patients with HIV prescribed stavudine.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Age and height predict neuropathy risk in patients with HIV prescribed stavudine.
@en
Age and height predict neuropathy risk in patients with HIV prescribed stavudine.
@nl
type
label
Age and height predict neuropathy risk in patients with HIV prescribed stavudine.
@en
Age and height predict neuropathy risk in patients with HIV prescribed stavudine.
@nl
prefLabel
Age and height predict neuropathy risk in patients with HIV prescribed stavudine.
@en
Age and height predict neuropathy risk in patients with HIV prescribed stavudine.
@nl
P2093
P1433
P1476
Age and height predict neuropathy risk in patients with HIV prescribed stavudine.
@en
P2093
A Kamarulzaman
C L Cherry
E Yunihastuti
J S Affandi
P304
P356
10.1212/WNL.0B013E3181AF7A22
P407
P577
2009-07-01T00:00:00Z